154 related articles for article (PubMed ID: 16502797)
1. [Anxiety disorders: long-term treatment and replapse prevention].
Bandelow VB; Wolff-Menzler C; Wedekind D; Rüther E
MMW Fortschr Med; 2006 Jan; 148(4):31-4. PubMed ID: 16502797
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of anxiety and panic attacks in geriatric psychiatry].
Madarasz K; Strnad J; Bahro M
Praxis (Bern 1994); 1998 Sep; 87(39):1252-4. PubMed ID: 9793416
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacotherapy of panic disorder].
Bougerol T; Farisse J
Encephale; 1996 Dec; 22 Spec No 5():46-53. PubMed ID: 9138947
[TBL] [Abstract][Full Text] [Related]
4. The assessment and treatment of refractory anxiety.
Hollander E; Cohen LJ
J Clin Psychiatry; 1994 Feb; 55 Suppl():27-31. PubMed ID: 7915712
[TBL] [Abstract][Full Text] [Related]
5. [Not Available].
Bandelow B; Wolff-Menzler C; Wedekind D; Rüther E
MMW Fortschr Med; 2006 Jan; 148(4):31-4. PubMed ID: 27387313
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and therapy of anxiety disorders].
Wacker HR
Ther Umsch; 1997 Jul; 54(7):380-5. PubMed ID: 9333986
[TBL] [Abstract][Full Text] [Related]
7. Treatments for generalized anxiety disorder.
Struzik L; Vermani M; Coonerty-Femiano A; Katzman MA
Expert Rev Neurother; 2004 Mar; 4(2):285-94. PubMed ID: 15853570
[TBL] [Abstract][Full Text] [Related]
8. Treatment of anxiety disorders with venlafaxine XR.
Thase ME
Expert Rev Neurother; 2006 Mar; 6(3):269-82. PubMed ID: 16533131
[TBL] [Abstract][Full Text] [Related]
9. Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
Sheehan DV; Raj AB; Harnett-Sheehan K; Dorotheo J; Sheehan MF; Trehan R; Knapp E; Swiontek A; Coleman B
Anxiety; 1996; 2(1):40-6. PubMed ID: 9160598
[No Abstract] [Full Text] [Related]
10. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
Lee JH; Dunner DL
Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
[TBL] [Abstract][Full Text] [Related]
11. Psychotherapeutic issues in long-term treatment of anxiety disorder patients.
Shear MK
Psychiatr Clin North Am; 1995 Dec; 18(4):885-94. PubMed ID: 8748387
[TBL] [Abstract][Full Text] [Related]
12. Social anxiety disorder under scrutiny.
Davidson JR
Depress Anxiety; 2000; 11(3):93-8. PubMed ID: 10875049
[TBL] [Abstract][Full Text] [Related]
13. Psychopharmacological treatment of dermatological patients--when simply talking does not help.
Harth W; Seikowski K; Gieler U; Niemeier V; Hillert A
J Dtsch Dermatol Ges; 2007 Dec; 5(12):1101-6. PubMed ID: 17877739
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacotherapy of Anxiety Disorders].
Zwanzger P
Fortschr Neurol Psychiatr; 2016 May; 84(5):306-14. PubMed ID: 27299791
[TBL] [Abstract][Full Text] [Related]
15. Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders.
Klein E; Malel D; Zilberman I; Lenox RH
Isr J Psychiatry Relat Sci; 1997; 34(4):265-9. PubMed ID: 9409083
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacotherapy].
Laux G
Ther Umsch; 1997 Oct; 54(10):595-9. PubMed ID: 9432751
[TBL] [Abstract][Full Text] [Related]
17. [The right drugs for panic and phobias. Managing anxiety in your patients].
Stiefelhagen P
MMW Fortschr Med; 2001 Sep; 143(37):16. PubMed ID: 11599286
[No Abstract] [Full Text] [Related]
18. Paroxetine in panic disorder: clinical management and long-term follow-up.
Dannon PN; Lowengrub K; Iancu I; Kotler M
Expert Rev Neurother; 2004 Mar; 4(2):191-8. PubMed ID: 15853560
[TBL] [Abstract][Full Text] [Related]
19. Maintenance treatment studies in anxiety disorders: some methodological notes.
Rickels K; Schweizer E
Psychopharmacol Bull; 1995; 31(1):115-23. PubMed ID: 7675975
[No Abstract] [Full Text] [Related]
20. Introduction. The multiplicity of uses of benzodiazepines.
Lapierre YD
Can J Psychiatry; 1993 Nov; 38 Suppl 4():S101. PubMed ID: 7905779
[No Abstract] [Full Text] [Related]
[Next] [New Search]
